0000939767-20-000157.txt : 20201117
0000939767-20-000157.hdr.sgml : 20201117
20201117201127
ACCESSION NUMBER: 0000939767-20-000157
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201115
FILED AS OF DATE: 20201117
DATE AS OF CHANGE: 20201117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MORRISSEY MICHAEL
CENTRAL INDEX KEY: 0001202096
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30235
FILM NUMBER: 201322598
MAIL ADDRESS:
STREET 1: C/O EXELIXIS INC
STREET 2: 170 HARBOR WAY
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94083
FORMER NAME:
FORMER CONFORMED NAME: MORRISSEY MICHAEL M
DATE OF NAME CHANGE: 20030512
FORMER NAME:
FORMER CONFORMED NAME: MORRISSEY MICHAEL R
DATE OF NAME CHANGE: 20021029
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXELIXIS, INC.
CENTRAL INDEX KEY: 0000939767
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 043257395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0101
BUSINESS ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
BUSINESS PHONE: 6508377000
MAIL ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS INC
DATE OF NAME CHANGE: 20000207
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20000106
4
1
wf-form4_160566187431677.xml
FORM 4
X0306
4
2020-11-15
0
0000939767
EXELIXIS, INC.
EXEL
0001202096
MORRISSEY MICHAEL
C/O EXELIXIS, INC.
1851 HARBOR BAY PARKWAY
ALAMEDA
CA
94502
1
1
0
0
President and CEO
Common Stock
2020-11-15
4
F
0
6526
20.16
D
592308
D
Common Stock
2020-11-15
4
F
0
10530
20.16
D
581778
D
Common Stock
2020-11-15
4
F
0
7898
20.16
D
573880
D
Common Stock
931635
I
By Trust
Common Stock
17728
I
By 401(k)
Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 10, 2018, for which the Compensation Committee certified that Exelixis, Inc. had achieved the performance goal on September 12, 2019.
Includes 386,641 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded on October 3, 2017.
Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded on September 26, 2016.
Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.
Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of November 13, 2020.
/s/ Jennifer Drimmer Rokovich, Attorney in Fact
2020-11-17